170 related articles for article (PubMed ID: 16867051)
1. The role of iNKT cells in development of bronchial asthma: a translational approach from animal models to human.
Akbari O
Allergy; 2006 Aug; 61(8):962-8. PubMed ID: 16867051
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic manipulation of iNKT cells in autoimmunity: modes of action and potential risks.
Mars LT; Novak J; Liblau RS; Lehuen A
Trends Immunol; 2004 Sep; 25(9):471-6. PubMed ID: 15324739
[TBL] [Abstract][Full Text] [Related]
3. Invariant NKT cells and tolerance.
Nowak M; Stein-Streilein J
Int Rev Immunol; 2007; 26(1-2):95-119. PubMed ID: 17454266
[TBL] [Abstract][Full Text] [Related]
4. Invariant and noninvariant natural killer T cells exert opposite regulatory functions on the immune response during murine schistosomiasis.
Mallevaey T; Fontaine J; Breuilh L; Paget C; Castro-Keller A; Vendeville C; Capron M; Leite-de-Moraes M; Trottein F; Faveeuw C
Infect Immun; 2007 May; 75(5):2171-80. PubMed ID: 17353286
[TBL] [Abstract][Full Text] [Related]
5. Invariant natural killer T (iNKT) cells in asthma: a novel insight into the pathogenesis of asthma and the therapeutic implication of glycolipid ligands for allergic diseases.
Oki S; Miyake S
Allergol Int; 2007 Mar; 56(1):7-14. PubMed ID: 17259804
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic potential of CD1d-restricted invariant natural killer T cell-based treatment for autoimmune diseases.
Miyake S; Yamamura T
Int Rev Immunol; 2007; 26(1-2):73-94. PubMed ID: 17454265
[TBL] [Abstract][Full Text] [Related]
7. A role for natural killer T cells in asthma.
Umetsu DT; DeKruyff RH
Nat Rev Immunol; 2006 Dec; 6(12):953-8. PubMed ID: 17068504
[TBL] [Abstract][Full Text] [Related]
8. Regulatory T cells in health and disease.
Rouse BT
J Intern Med; 2007 Jul; 262(1):78-95. PubMed ID: 17598816
[TBL] [Abstract][Full Text] [Related]
9. Regulatory T cells control the development of allergic disease and asthma.
Umetsu DT; Akbari O; Dekruyff RH
J Allergy Clin Immunol; 2003 Sep; 112(3):480-7; quiz 488. PubMed ID: 13679803
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms in allergic airway inflammation - lessons from studies in the mouse.
Shum BO; Rolph MS; Sewell WA
Expert Rev Mol Med; 2008 May; 10():e15. PubMed ID: 18503727
[TBL] [Abstract][Full Text] [Related]
11. The development of airway hyperreactivity in T-bet-deficient mice requires CD1d-restricted NKT cells.
Kim HY; Pichavant M; Matangkasombut P; Koh YI; Savage PB; DeKruyff RH; Umetsu DT
J Immunol; 2009 Mar; 182(5):3252-61. PubMed ID: 19234223
[TBL] [Abstract][Full Text] [Related]
12. Co-stimulatory molecules as potential targets for therapeutic intervention in allergic airway disease.
Kallinich T; Beier KC; Gelfand EW; Kroczek RA; Hamelmann E
Clin Exp Allergy; 2005 Dec; 35(12):1521-34. PubMed ID: 16393317
[TBL] [Abstract][Full Text] [Related]
13. Invariant natural killer T cells: innate-like T cells with potent immunomodulatory activities.
Wu L; Gabriel CL; Parekh VV; Van Kaer L
Tissue Antigens; 2009 Jun; 73(6):535-45. PubMed ID: 19392798
[TBL] [Abstract][Full Text] [Related]
14. Innate immunity modulates autoimmunity: type 1 interferon-beta treatment in multiple sclerosis promotes growth and function of regulatory invariant natural killer T cells through dendritic cell maturation.
Gigli G; Caielli S; Cutuli D; Falcone M
Immunology; 2007 Nov; 122(3):409-17. PubMed ID: 17617156
[TBL] [Abstract][Full Text] [Related]
15. In vitro expanded human invariant natural killer T-cells promote functional activity of natural killer cells.
Moreno M; Molling JW; von Mensdorff-Pouilly S; Verheijen RH; von Blomberg BM; van den Eertwegh AJ; Scheper RJ; Bontkes HJ
Clin Immunol; 2008 Oct; 129(1):145-54. PubMed ID: 18707922
[TBL] [Abstract][Full Text] [Related]
16. iNKT cells in allergic disease.
Meyer EH; DeKruyff RH; Umetsu DT
Curr Top Microbiol Immunol; 2007; 314():269-91. PubMed ID: 17593665
[TBL] [Abstract][Full Text] [Related]
17. Regulatory T cells and asthma.
Robinson DS
Clin Exp Allergy; 2009 Sep; 39(9):1314-23. PubMed ID: 19538496
[TBL] [Abstract][Full Text] [Related]
18. PKCtheta: A potential therapeutic target for T-cell-mediated diseases.
Chaudhary D; Kasaian M
Curr Opin Investig Drugs; 2006 May; 7(5):432-7. PubMed ID: 16729719
[TBL] [Abstract][Full Text] [Related]
19. Granulocyte-macrophage colony-stimulating factor regulates effector differentiation of invariant natural killer T cells during thymic ontogeny.
Bezbradica JS; Gordy LE; Stanic AK; Dragovic S; Hill T; Hawiger J; Unutmaz D; Van Kaer L; Joyce S
Immunity; 2006 Sep; 25(3):487-97. PubMed ID: 16949316
[TBL] [Abstract][Full Text] [Related]
20. Understanding the behavior of invariant NKT cells in autoimmune diseases.
Yamamura T; Sakuishi K; Illés Z; Miyake S
J Neuroimmunol; 2007 Nov; 191(1-2):8-15. PubMed ID: 17905445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
